Bills › 90th General Assembly
Relating to insurance coverage for prescription insulin drugs
Topics:Business & economyHealth carePrescription drug prices
Where it is now
- Done: IntroducedJanuary 17, 2024
- Done: SubcommitteeJanuary 24, 2024
- Stopped: Senate committeeDied when the General Assembly ended
- Next: Passes the Senate
- Next: House committee
- Next: Passes the House
- Next: To the Governor
- Next: Signed into law
Died when the session ended The General Assembly adjourned on April 19, 2024. Bills that didn’t pass both chambers died. What’s a funnel?
What’s in it
This bill relates to prescription insulin drugs and coverage by policies, contracts, or plans providing for third-party payment or prepayment of health or medical expenses that provide coverage for prescription drugs. The bill requires a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses that provides coverage for prescription drugs to cap the total amount of cost-sharing that a covered person is required to pay per prescription filled of an insulin drug to an amount not more than $25 for an up to 31-day supply of at least one type of rapid-acting prescription insulin drugs, short-acting prescription insulin drugs, intermediate-acting prescription insulin drugs, or long-acting prescription insulin drugs.
Read the full explanation
“Prescription insulin drug” is defined in the bill as a prescription drug that contains insulin, is used to treat diabetes, has been prescribed as medically necessary by a covered person’s health care professional, and is a benefit covered by a covered person’s policy, contract, or plan. The bill defines “cost-sharing” as any coverage limit, copayment, coinsurance, deductible, or other out-of-pocket expense imposed on a covered person. The bill does not prohibit a policy, contract, or plan providing for third-party payment or prepayment of health or medical expenses from reducing a covered person’s cost-sharing to less than $25 for up to a 31-day supply of a prescription insulin drug. The bill applies to third-party payment provider contracts, policies, or plans delivered, issued for delivery, continued, or renewed in this state on or after January 1, 2025, by the third-party payment providers enumerated in the bill. The bill specifies the types of specialized health-related insurance which are not subject to the coverage requirements of the bill. The commissioner of insurance may adopt rules to administer the requirements of the bill.
From the explanation printed with the bill as introduced, written by the Legislative Services Agency. Amendments adopted later aren’t reflected. Full bill text
Senate subcommittee
Named January 24, 2024. It hasn’t reported yet.
Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part
Iowa Code it changes
Creates§514C.18A
Read from the bill as introduced. Each links to every bill touching that chapter of the Iowa Code. How the Code works
Lobbying
1 for · 1 against · 4 undecided · Who →
Family tree
Where this legislation came from and where it went: earlier tries, the versions it moved through this Assembly, and later bills built on it.
90th General Assembly
Earlier and later bills are matched by wording or an identical title; check the text to be sure it’s the same idea.
Tried before
This idea has been filed in an earlier General Assembly. None became law, though one got through a chamber.
- HF 2138 Relating to insurance coverage for prescription insulin drugs88th General Assembly · Passed House · same titlePassed a chamber
- SF 2113 Relating to insurance coverage for prescription insulin drugs88th General Assembly · In committee · same titleCleared committee
Similar bills this General Assembly
- HF 405 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- HF 658 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- SF 2047 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- HF 502 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeNearly identical
- HF 694 Relating to insurance coverage for prescription insulin drugs90th General Assembly · In committeeNearly identical
- SF 2322 Relating to insurance coverage for prescription insulin drugs91st General Assembly · In committeeNearly identical
- SF 2214 Relating to insurance coverage for prescription insulin drugs90th General Assembly · Approved by committeeNearly identical
Matched by the wording of each bill’s explanation, or an identical title. Companion bills and renumbered versions of this bill aren’t listed; they’re the same bill.